Related Experiment Videos
Correlation between age and plasma level/dosage ratio for phenobarbital in infants and children
Insights
Phenobarbital dosage in children significantly correlates with age, with higher plasma levels per dose in older children. Regular monitoring of phenobarbital plasma levels is recommended for pediatric patients.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Clinical Pharmacy
Background:
- Phenobarbital is a widely used anticonvulsant in pediatric populations.
- Accurate dosing is crucial for efficacy and safety, but pediatric pharmacokinetics can vary significantly with age.
- Understanding age-related changes in phenobarbital disposition is essential for optimizing treatment.
Purpose of the Study:
- To investigate the relationship between phenobarbital plasma concentration, dosage, and patient age in children.
- To provide practical guidelines for phenobarbital dosing in different pediatric age groups.
- To highlight the importance of therapeutic drug monitoring in children.
Main Methods:
- Analysis of 123 steady-state plasma phenobarbital concentrations from 82 children aged 2 months to 6.5 years.
- Correlation analysis of plasma level/dosage ratios with patient age, considering dosage in mg/kg and mg/m².
- Evaluation of age-related trends in phenobarbital plasma levels.
Main Results:
- A highly significant correlation was observed between the plasma level/dosage ratio and patient age.
- This ratio increased with age, particularly for dosages calculated on a body weight basis (mg/kg).
- The increase was most pronounced in the first year of life, diminishing thereafter.
Conclusions:
- Phenobarbital dosage requirements in children are significantly influenced by age.
- Dosages expressed per body weight show a greater age-related increase in plasma levels.
- Regular plasma phenobarbital level monitoring is recommended for infants and children on long-term therapy.
Abstract:
123 plasma concentration measurements of phenobarbital were obtained from 82 children (2 months - 6 1/2 years old) at steady-state conditions. The plasma level/dosage ratio has been found to have a highly significant correlation with the age of the patient both for dosage in mg/kg and in mg/m2. The ratio increases with the increase in the age of the patient at a rate which is greater for dosages expressed on the basis of body weight. Moreover, at least for body weight related dosages, this increase is relatively high in the first year of life, becoming less marked after. Practical indications are given about the required dosage of phenobarbital in different groups of ages from 2 months to 6 1/2 years. It is recommended however to regularly measure the plasma level of the drug in infants and children treated for long periods of time.